ArticleHuman genomics2026
Exploration of neutrophil-associated genes in the prognosis of bladder urothelial carcinoma based on a machine learning and multi-omics data integration framework.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBladder urothelial carcinoma (BLCA) is a prevalent malignancy. The poor performance of existing therapeutic approaches in the advanced stages of BLCA underscores the critical need for more sensitive and precise biomarkers to improve patient survival and prognosis.
methodsThis study utilized single-cell RNA sequencing (scRNA-seq) data from BLCA and control groups, employing the high-dimensional Weighted Gene Co-expression Network Analysis (hdWGCNA) algorithm to identify neutrophil-associated genes. These genes were intersected with differentially expressed genes (DEGs) from RNA-seq data, followed by univariate Cox regression analysis. Subsequently, BLCA subtypes were identified using a framework combining autoencoder (DAE) and joint deep semi-nonnegative matrix factorization algorithms. Various machine learning ensemble algorithms were then used to screen prognostic genes and construct a BLCA risk model.
resultsWe identified several reliable BLCA subtypes with significant differences in enriched pathways and immune landscapes. Based on the risk model, the high- and low-risk groups showed significant differences in the expression patterns and BLCA-related associations of prognostic genes, as well as in immune cell correlations and drug sensitivity. Furthermore, the prognostic genes in the constructed risk model also demonstrated significant value in pan-cancer analysis.
conclusionThis study reveals the critical role of neutrophils in the occurrence and progression of BLCA through multi-omics data and bioinformatics analyses, and constructs a risk model with potential clinical applications. Our research provides new insights for precise stratification and personalized treatment of BLCA, promising to improve the clinical prognosis. The source code for the proposed framework is available at https://gitee.com/guancheng-xiao/blca/tree/master/ .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.